TRILOSTANE IN THE MANAGEMENT OF CUSHINGS-SYNDROME

被引:28
作者
SEMPLE, CG [1 ]
BEASTALL, GH [1 ]
GRAY, CE [1 ]
THOMSON, JA [1 ]
机构
[1] UNIV GLASGOW,GLASGOW ROYAL INFIRM,DEPT PATHOL BIOCHEM,GLASGOW,SCOTLAND
来源
ACTA ENDOCRINOLOGICA | 1983年 / 102卷 / 01期
关键词
D O I
10.1530/acta.0.1020107
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:107 / 110
页数:4
相关论文
共 10 条
  • [1] BAKER JF, 1980, ARCH INT PHARMACOD T, V243, P4
  • [2] BEASTALL GH, 1981, LANCET, V1, P727
  • [3] DARLING JAB, 1981, ACTA ENDOCR-COP S, V243, P291
  • [4] METYRAPONE IN LONG-TERM MANAGEMENT OF CUSHINGS-DISEASE
    JEFFCOATE, WJ
    REES, LH
    TOMLIN, S
    JONES, AE
    EDWARDS, CRW
    BESSER, GM
    [J]. BRITISH MEDICAL JOURNAL, 1977, 2 (6081) : 215 - 217
  • [5] TREATMENT OF CUSHINGS-SYNDROME WITH TRILOSTANE (WIN-24,540), AN INHIBITOR OF ADRENAL-STEROID BIOSYNTHESIS
    KOMANICKY, P
    SPARK, RF
    MELBY, JC
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1978, 47 (05) : 1042 - 1051
  • [7] MATTINGLY D, 1981, LANCET, V1, P561
  • [8] POTTS G O, 1975, Endocrinology, V96, P58
  • [9] TRILOSTANE, AN ORALLY ACTIVE INHIBITOR OF STEROID BIOSYNTHESIS
    POTTS, GO
    CREANGE, JE
    HARDING, HR
    SCHANE, HP
    [J]. STEROIDS, 1978, 32 (02) : 257 - 267
  • [10] CUSHINGS-DISEASE - 18 YEARS EXPERIENCE
    URBANIC, RC
    GEORGE, JM
    [J]. MEDICINE, 1981, 60 (01) : 14 - 24